Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Conquering Insulin Network Dysfunctions in Alzheimer’s Disease: Where Are We Today?

Journal of Alzheimer s Disease(2024)10.3233/jad-240069Source: DataRank Database

Conquering Insulin Network Dysfunctions in Alzheimer’s Disease: Where Are We Today? is a research paper published in Journal of Alzheimer s Disease (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.38)OA: greenTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Suzanne M. de la Monte ORCID

Live enrichment

PubMed:39422949 PMC:PMC11807374 OpenAlex:https://openalex.org/W4403538556

NIAAA NIH HHS

Grant: R01 AA011431

NIAAA NIH HHS

Grant: R37 AA011431

NIAAA NIH HHS

Grant: R01 AA028408

NIAAA NIH HHS

Grant: R56 AA011431

FWCI

4.38

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11807374/pdf/nihms-2052156.pdf

publisherhttps://content.iospress.com/download?id=10.3233/JAD-240069

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11807374

journalhttps://doi.org/10.3233/jad-240069

Fields of Study

Alzheimer's disease research and treatmentsRegulation of Appetite and ObesityNatural Antidiabetic Agents Studies

MeSH Terms

Glucagon-Like Peptide-1 Receptor AgonistsAlzheimer DiseaseAnimalsBrainClinical Trials as TopicDisease Models, AnimalEnergy MetabolismHumansHypoglycemic AgentsInsulinInsulin ResistanceNeuronal PlasticitySignal TransductionPeroxisome Proliferator-Activated ReceptorsDrug RepositioningCognitive Dysfunction

Keywords

NeuroinflammationInsulin receptorInsulinNeurodegenerationMedicineCognitive declineNeuroprotectionDiabetes mellitusNeuroscienceDementiaInternal medicineInsulin resistanceEndocrinologyDiseaseBiologyVascular dementiaAlzheimer’s diseaseIncretinInsulin SensitizerIntranasal InsulinType 3 DiabetesDiabetes DrugsPpar Agonist

Sustainable Development Goals

SDG 0: Good health and well-being